Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23403684 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth
Conditions: Malaria;   Sexually Transmitted Diseases;   Preterm Birth;   Pregnancy
Interventions: Drug: Sulfadoxine-pyrimethamine treatment twice during pregnancy;   Drug: Sulfadoxine-pyrimethamine at 4-week intervals;   Drug: Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twice

Indicates status has not been verified in more than two years